Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Comorbidities in early and late onset psoriatic patients (CROSBI ID 535830)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Stanić-Žgombić, Zrinka ; Manestar-Blažić, Teo ; Laginja, Stanislava ; Prpić Massari, Larisa ; Brajac, Ines ; Kaštelan, Marija Comorbidities in early and late onset psoriatic patients // 16th Congress European Academy of Dermatology & Venereology, Abstracts on CD-ROM. 2007. str. P1161-x

Podaci o odgovornosti

Stanić-Žgombić, Zrinka ; Manestar-Blažić, Teo ; Laginja, Stanislava ; Prpić Massari, Larisa ; Brajac, Ines ; Kaštelan, Marija

engleski

Comorbidities in early and late onset psoriatic patients

Aims: To examine the prevalence of comorbidities in hospitalized patients with early and late onset psoriasis. Methods: Medical records of 143 patients with early and 117 patients with late onset psoriasis, hospitalized at Department of dermatovenerology during a 10-year period (1996-2005), were analyzed. Results: The mean age of psoriatic patients was 24.19&plusmn ; 8.39 years in early onset and 54.46&plusmn ; 10.17 years in late onset psoriasis, respectively. The incidence of hypertension (6.16% vs 18.80%), and ischaemic hearth disease (0.70% vs 7.69%) was higher in late onset group although the difference was not statistically significant. There was no difference in the incidence of diabetes (3.59% vs 3.41%) between two examined groups of psoriatic patients, while the incidence of CVI was slightly higher in early onset (1.40% vs 0.85%) psoriasis. Laboratory data showed that hypertrigliceridaemia (7.69% vs 14.59%) and hypercholesterolaemia (15.38% vs 23.39%) were more frequent in late onset group of patients. Conclusion: In our study, we confirmed the existence of comorbidities in psoriatic patients with early and late onset psoriasis. However, we did not find any statistical difference in the prevalence of comorbidities between these groups of patients.

Psoriasis; Comorbidities

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

P1161-x.

2007.

objavljeno

Podaci o matičnoj publikaciji

16th Congress European Academy of Dermatology & Venereology, Abstracts on CD-ROM

Podaci o skupu

16th Congress European Academy of Dermatology & Venereology

poster

16.05.2007-20.05.2007

Beč, Austrija

Povezanost rada

Kliničke medicinske znanosti